October 1 update. Our PDGM and ICD-10 tools now use the FY2027 code set: 190 codes added, 30 deleted, and no existing code changed clinical group.

See what changed

ICD-10 · PDGM grouping

Z15 Genetic susceptibility to disease

All 14 codes in the Z15 family, with the PDGM clinical group, comorbidity subgroup and primary-position rule CMS assigns, read from the CMS grouper crosswalk v07.2.26 and the CDC FY2027 code file.

ICD-10-CM FY2027 · CMS grouper v07.2.26

Codes in family

14

Can lead a claim

0

Cannot lead a claim

14

What CMS assigns to Z15

None of the 14 codes is assigned a clinical group. None of the 14 is assigned a comorbidity subgroup. None can lead a claim. CMS attaches a code-first note to 9 of the 14.

Code first

CMS grouper convention 173, on Z15.01, Z15.02, Z15.03, Z15.04, Z15.05, Z15.060, Z15.068, Z15.07, Z15.09. Code first:

  • , if applicable, any current malignant neoplasm (C00-C75, C81-C96)

Every code in Z15

Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.

CodeDescriptionPrimary positionClinical groupComorbidity subgroup
Z15.0 Genetic susceptibility to malignant neoplasm
Z15.01Genetic susceptibility to malignant neoplasm of breastCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
Z15.02Genetic susceptibility to malignant neoplasm of ovaryCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
Z15.03Genetic susceptibility to malignant neoplasm of prostateCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
Z15.04Genetic susceptibility to malignant neoplasm of endometriumCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
Z15.05Genetic susceptibility to malignant neoplasm of fallopian tube(s)CMS: Genetic susceptibility to malignant neoplasm of fallop(s)Cannot lead a claimUnacceptable principal diagnosis, code is not reportable as principal diagnosisNoneNone
Z15.06 Genetic susceptibility to malignant neoplasm of digestive system
Z15.060Genetic susceptibility to colorectal cancerCannot lead a claimUnacceptable principal diagnosis, code is not reportable as principal diagnosisNoneNone
Z15.068Genetic susceptibility to other malignant neoplasm of digestive systemCMS: Genetic susceptibility to other malig neoplasm of dgstv sysCannot lead a claimUnacceptable principal diagnosis, code is not reportable as principal diagnosisNoneNone
Z15.07Genetic susceptibility to malignant neoplasm of urinary tractCMS: Genetic susceptibility to malig neoplasm of urinary tractCannot lead a claimUnacceptable principal diagnosis, code is not reportable as principal diagnosisNoneNone
Z15.09Genetic susceptibility to other malignant neoplasmCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
Z15.1Genetic susceptibility to epilepsy and neurodevelopmental disordersCMS: Genetic susceptibility to epi and neurodevelopmental disordCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
Z15.2Genetic susceptibility to obesityCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
Z15.3Genetic susceptibility to kidney diseaseCannot lead a claimUnacceptable principal diagnosis, code is not reportable as principal diagnosisNoneNone
Z15.8 Genetic susceptibility to other disease
Z15.81Genetic susceptibility to multiple endocrine neoplasia [MEN]Cannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
Z15.89Genetic susceptibility to other diseaseCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone

Sources: CMS HH PPS Grouper Software v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.

The monthly home health regs digest

What CMS changed, what's due next, and what to do about it — one email a month, no fluff. Read the first issue